Why do some drug-based strategies shorten the lives of diabetics and some diet-based strategies fail to decrease diabetes deaths?
When Drugs and Diets Don’t Lower Diabetes Deaths
People with type 2 diabetes are at elevated risk for a number of serious health problems, including heart disease, premature death, blindness, kidney failure, amputations, fractures, frailty, depression, and cognitive decline. And, the higher people’s blood sugars are, the more heart attacks and strokes they have, the shorter their lifespans, and the higher their risk of complications like blindness and kidney failure. So, a study was designed in which 10,000 diabetics were randomized into an intensive blood sugar lowering intervention, where they put people on 1, 2, 3, 4, or 5 different classes of drugs, with or without insulin, to drive blood sugars into the normal range. Of course, you’re not treating the underlying cause; they’re not treating the actual disease, but by lowering one of the effects of the disease by any means necessary, the hope was to prevent some of the devastating complications. How’d they do?
The intensive blood sugar lowering with drugs increased mortality. After reviewing mortality trends, they concluded that the harm associated with the increased rate of death outweighed any potential benefits and they stopped the study prematurely for safety reasons. They were successful in bringing people’s blood sugars down, but in trying to push people’s A1c under six, they ended up pushing people six feet under, perhaps due to the adverse effects of the very drugs used to treat the disease.
Even just injected insulin itself may promote cancer, obesity, and atherosclerosis, worsen diabetic retinopathy, and accelerate aging. Insulin therapy may promote inflammation in the lining of our arteries, which may help explain the results in this trial and other trials that showed the same thing: no reduction in so-called macrovascular complications, heart attacks, and strokes, with intensive blood sugar lowering. However, intensive therapy was associated with a 21% reduction in the development of microvascular complications like kidney dysfunction.
But any such benefits should be weighed against the increased risk of dying, increased weight gain, and increased risk of severe hypoglycaemia in intensively-treated patients. So, trying to normalize people’s blood sugars with drugs may not be such a good idea.
It should be noted, though, that these trials relied virtually exclusively on drugs and did not include any serious effort at diet and lifestyle change.
A 2013 paper in the New England Journal of Medicine found that an intensive lifestyle intervention focusing on weight loss did not reduce the rate of cardiovascular events like heart attacks in overweight or obese adults with type 2 diabetes. It didn’t increase their risk of death, but it didn’t seem to decrease it. In fact, the trial was just stopped after about ten years on the basis of futility—they lost weight, but they weren’t dying any less. And, that’s what we see across the board with these types of lifestyle interventions. It’s good that the dietary intervention wasn’t killing anyone, but why wasn’t it actually helping people live longer?
Because they didn’t actually put them on a healthier diet; they just put them on a smaller diet, a calorie restricted diet, meaning essentially the same lousy diet, but just in smaller portions. If we eat less and exercise more, we can lose weight, get more physically fit, slimmer and have better blood sugar control, but if our diets continue to be so unheart-healthy that our “bad” LDL cholesterol doesn’t improve, then we’re not going to be unclogging our arteries. Whereas, individuals following healthier diets may experience improved reductions in blood sugar, body weight, and cardiovascular risk. Yes, by eating a smaller quantity of food, without changing quality, we can lose weight, but the point of a lifestyle intervention is not to just fit people into skinnier caskets.
To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video. This is just an approximation of the audio contributed by Katie Schloer.
Please consider volunteering to help out on the site.
- E S Schellenberg, D M Dryden, B Vandermeer, C Ha, C Korownyk. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013 Oct 15;159(8):543-51.
- R Madonna, A Pandolfi, M Massaro, A Consoli, R De Caterina. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004 Mar;47(3):532-6. Epub 2004 Feb 5.
- Look AHEAD Research Group, RR Wing, P Bolin, F L Brancati, G A Bray, J M Clark, M Coday, R S Crow, J M Curtis, C M Egan, M A Espeland, M Evans, J P Foreyt, S Ghazarian, E W Gregg, B Harrison, H P Hazuda, J O Hil, E S Horton, V S Hubbard, J M Jakicic, R W Jeffery, K C Johnson, S E Kahn, A E Kitabchi, W C Knowler, C E Lewis, B J Maschak-Carey, M G Montez, A Murillo, D M Nathan, J Patricio, A Peters, X Pi-Sunyer, H Pownall, D Reboussin, J G Regensteiner, A D Rickman, D H Ryan, M Safford, T A Wadden, L E Wagenknecht, D S West, D F Williamson, S Z Yanovski. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145-54.
- C B Trapp, N D Barnard. Usefulness of vegetarian and vegan diets for treating type 2 diabetes. Curr Diab Rep. 2010 Apr;10(2):152-8.
- M V Blagosklonny. Prospective treatment of age-related diseases by slowing down aging. Am J Pathol. 2012 Oct;181(4):1142-6.
- F Ismail-Beigi, T Craven, M A Banerji, J Basile, J Calles, R M Cohen, R Cuddihy, W C Cushman , S Genuth, R H Grimm Jr, B P Hamilton, B Hoogwerf, D Karl, L Katz, A Krikorian, P O'Connor, R Pop-Busui, U Schubart, D Simmons, H Taylor, A Thomas, D Weiss, I Hramiak; ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010 Aug 7;376(9739):419-30.
- T Terry, K Raravikar, N Chokrungvaranon, P D Reaven. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep. 2012 Feb;14(1):79-88.
- P Kishore, S H Kim, J P Crandall. Glycemic control and cardiovascular disease: what's a doctor to do? Curr Diab Rep. 2012 Jun;12(3):255-64.
- E R Jenny-Avital. Intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct 2;359(14):1519; author reply 1520-1.
- Action to Control Cardiovascular Risk in Diabetes Study Group, H C Gerstein, M E Miller, R P Byington, D C Goff Jr, J T Bigger, J B Buse, W C Cushman, S Genuth, F Ismail-Beigi, R H Grimm Jr, J L Probstfield, D G Simons-Morton, W T Friedewald. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59.
Thumbnail image thanks to Pixabay. Video image from Jakub T. Jankiewicz via Flickr.
- aging
- blood sugar
- bone fractures
- caloric restriction
- cancer
- cardiovascular disease
- cholesterol
- cognition
- depression
- diabetes
- exercise
- eye health
- heart disease
- insulin
- kidney disease
- kidney failure
- LDL cholesterol
- lifespan
- lifestyle medicine
- longevity
- medications
- mental health
- mood
- mortality
- obesity
- prediabetes
- vision
- weight gain
- weight loss
People with type 2 diabetes are at elevated risk for a number of serious health problems, including heart disease, premature death, blindness, kidney failure, amputations, fractures, frailty, depression, and cognitive decline. And, the higher people’s blood sugars are, the more heart attacks and strokes they have, the shorter their lifespans, and the higher their risk of complications like blindness and kidney failure. So, a study was designed in which 10,000 diabetics were randomized into an intensive blood sugar lowering intervention, where they put people on 1, 2, 3, 4, or 5 different classes of drugs, with or without insulin, to drive blood sugars into the normal range. Of course, you’re not treating the underlying cause; they’re not treating the actual disease, but by lowering one of the effects of the disease by any means necessary, the hope was to prevent some of the devastating complications. How’d they do?
The intensive blood sugar lowering with drugs increased mortality. After reviewing mortality trends, they concluded that the harm associated with the increased rate of death outweighed any potential benefits and they stopped the study prematurely for safety reasons. They were successful in bringing people’s blood sugars down, but in trying to push people’s A1c under six, they ended up pushing people six feet under, perhaps due to the adverse effects of the very drugs used to treat the disease.
Even just injected insulin itself may promote cancer, obesity, and atherosclerosis, worsen diabetic retinopathy, and accelerate aging. Insulin therapy may promote inflammation in the lining of our arteries, which may help explain the results in this trial and other trials that showed the same thing: no reduction in so-called macrovascular complications, heart attacks, and strokes, with intensive blood sugar lowering. However, intensive therapy was associated with a 21% reduction in the development of microvascular complications like kidney dysfunction.
But any such benefits should be weighed against the increased risk of dying, increased weight gain, and increased risk of severe hypoglycaemia in intensively-treated patients. So, trying to normalize people’s blood sugars with drugs may not be such a good idea.
It should be noted, though, that these trials relied virtually exclusively on drugs and did not include any serious effort at diet and lifestyle change.
A 2013 paper in the New England Journal of Medicine found that an intensive lifestyle intervention focusing on weight loss did not reduce the rate of cardiovascular events like heart attacks in overweight or obese adults with type 2 diabetes. It didn’t increase their risk of death, but it didn’t seem to decrease it. In fact, the trial was just stopped after about ten years on the basis of futility—they lost weight, but they weren’t dying any less. And, that’s what we see across the board with these types of lifestyle interventions. It’s good that the dietary intervention wasn’t killing anyone, but why wasn’t it actually helping people live longer?
Because they didn’t actually put them on a healthier diet; they just put them on a smaller diet, a calorie restricted diet, meaning essentially the same lousy diet, but just in smaller portions. If we eat less and exercise more, we can lose weight, get more physically fit, slimmer and have better blood sugar control, but if our diets continue to be so unheart-healthy that our “bad” LDL cholesterol doesn’t improve, then we’re not going to be unclogging our arteries. Whereas, individuals following healthier diets may experience improved reductions in blood sugar, body weight, and cardiovascular risk. Yes, by eating a smaller quantity of food, without changing quality, we can lose weight, but the point of a lifestyle intervention is not to just fit people into skinnier caskets.
To see any graphs, charts, graphics, images, and quotes to which Dr. Greger may be referring, watch the above video. This is just an approximation of the audio contributed by Katie Schloer.
Please consider volunteering to help out on the site.
- E S Schellenberg, D M Dryden, B Vandermeer, C Ha, C Korownyk. Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis. Ann Intern Med. 2013 Oct 15;159(8):543-51.
- R Madonna, A Pandolfi, M Massaro, A Consoli, R De Caterina. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia. 2004 Mar;47(3):532-6. Epub 2004 Feb 5.
- Look AHEAD Research Group, RR Wing, P Bolin, F L Brancati, G A Bray, J M Clark, M Coday, R S Crow, J M Curtis, C M Egan, M A Espeland, M Evans, J P Foreyt, S Ghazarian, E W Gregg, B Harrison, H P Hazuda, J O Hil, E S Horton, V S Hubbard, J M Jakicic, R W Jeffery, K C Johnson, S E Kahn, A E Kitabchi, W C Knowler, C E Lewis, B J Maschak-Carey, M G Montez, A Murillo, D M Nathan, J Patricio, A Peters, X Pi-Sunyer, H Pownall, D Reboussin, J G Regensteiner, A D Rickman, D H Ryan, M Safford, T A Wadden, L E Wagenknecht, D S West, D F Williamson, S Z Yanovski. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013 Jul 11;369(2):145-54.
- C B Trapp, N D Barnard. Usefulness of vegetarian and vegan diets for treating type 2 diabetes. Curr Diab Rep. 2010 Apr;10(2):152-8.
- M V Blagosklonny. Prospective treatment of age-related diseases by slowing down aging. Am J Pathol. 2012 Oct;181(4):1142-6.
- F Ismail-Beigi, T Craven, M A Banerji, J Basile, J Calles, R M Cohen, R Cuddihy, W C Cushman , S Genuth, R H Grimm Jr, B P Hamilton, B Hoogwerf, D Karl, L Katz, A Krikorian, P O'Connor, R Pop-Busui, U Schubart, D Simmons, H Taylor, A Thomas, D Weiss, I Hramiak; ACCORD trial group. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet. 2010 Aug 7;376(9739):419-30.
- T Terry, K Raravikar, N Chokrungvaranon, P D Reaven. Does aggressive glycemic control benefit macrovascular and microvascular disease in type 2 diabetes? Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep. 2012 Feb;14(1):79-88.
- P Kishore, S H Kim, J P Crandall. Glycemic control and cardiovascular disease: what's a doctor to do? Curr Diab Rep. 2012 Jun;12(3):255-64.
- E R Jenny-Avital. Intensive glucose control in type 2 diabetes. N Engl J Med. 2008 Oct 2;359(14):1519; author reply 1520-1.
- Action to Control Cardiovascular Risk in Diabetes Study Group, H C Gerstein, M E Miller, R P Byington, D C Goff Jr, J T Bigger, J B Buse, W C Cushman, S Genuth, F Ismail-Beigi, R H Grimm Jr, J L Probstfield, D G Simons-Morton, W T Friedewald. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008 Jun 12;358(24):2545-59.
Thumbnail image thanks to Pixabay. Video image from Jakub T. Jankiewicz via Flickr.
- aging
- blood sugar
- bone fractures
- caloric restriction
- cancer
- cardiovascular disease
- cholesterol
- cognition
- depression
- diabetes
- exercise
- eye health
- heart disease
- insulin
- kidney disease
- kidney failure
- LDL cholesterol
- lifespan
- lifestyle medicine
- longevity
- medications
- mental health
- mood
- mortality
- obesity
- prediabetes
- vision
- weight gain
- weight loss
Republishing "When Drugs and Diets Don’t Lower Diabetes Deaths"
You may republish this material online or in print under our Creative Commons licence. You must attribute the article to NutritionFacts.org with a link back to our website in your republication.
If any changes are made to the original text or video, you must indicate, reasonably, what has changed about the article or video.
You may not use our material for commercial purposes.
You may not apply legal terms or technological measures that restrict others from doing anything permitted here.
If you have any questions, please Contact Us
When Drugs and Diets Don’t Lower Diabetes Deaths
LicenseCreative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Content URLDoctor's Note
OK, so what kind of diet does help diabetics? See Plant-Based Diets and Diabetes, for example, or Diabetics Should Take Their Pulses.
Why is that the case? See Why is Meat a Risk Factor for Diabetes? and How May Plants Protect Against Diabetes?
Healthier diets can even reverse some of the complications of diabetes once thought irreversible. See Can Diabetic Retinopathy Be Reversed? and the part of my annual review From Table to Able: Combating Disabling Diseases with Food that discusses the remarkable reversal of painful diabetic neuropathy.
If you haven't yet, you can subscribe to our free newsletter. With your subscription, you'll also get notifications for just-released blogs and videos. Check out our information page about our translated resources.